Версия для слабовидящих:
Размер шрифта:
a
a
a

World Conference on Lung Cancer, September 7-10, 2019, Barcelona, Spain

  • Main
  • News
  • World Conference on Lung Cancer, September 7-10, 2019, Barcelona, Spain
On September 7-10, 2019, the World Conference on Lung Cancer (IASLC World Conference on Lung Cancer 2019) was held in Barcelona (Spain). The conference was attended by about 7000 specialists in the field of lung cancer from more than 100 countries. The conference addressed a wide range of issues related to both basic research on the mechanisms of carcinogenesis,

In Models and Biomarkers session, E.V. Denisov, PhD, Head of Laboratory of Tumor Progression Biology, Tomsk National Research Medical Center, made an oral presentation on the decoding of the molecular mechanisms underlying the pre-tumor changes preceding squamous cell lung cancer. He presented data on genes involved in progression of hyperplasia and metaplasia to dysplasia and ultimately to lung cancer. The presented results were obtained during the implementation of the project “Molecular markers of the progression / inhibition of morphological changes in bronchial epithelium to predict the risk of developing squamous cell lung cancer” (RFBR grant No. 17-29-06002) and published in the journal Applied Immunohistochemistry & Molecular Morphology in 2019 (https://www.ncbi.nlm.nih.gov/pubmed/30896548).
All oral presentations were analyzed and discussed. Dr. Lakis Liloglou from the Institute of Translational Medicine, University of Liverpool (UK) emphasized the novelty of the results presented by E.V. Denisova, and research originality in the study of precancerous changes in lung cancer. In addition, Dr. Liloglou highlighted the importance of studying the causes of malignant transformation of pre-tumor changes and developing non-invasive markers to predict the risk of lung cancer.
To participate in the conference, E.V. Denisov received a travel grant from the organizing committee: WCLC 2019 Developing Nation Award.

Conference website


At the World Conference on Lung Cancer (IASLC World Conference on Lung Cancer 2019), September 7-10, 2019 in Barcelona (Spain), E.V. Denisov, PhD, Head of Laboratory of Tumor Progression Biology, Tomsk National Research Medical Center, made an oral presentation and presented data on genes involved in progression of hyperplasia and metaplasia to dysplasia and ultimately to lung cancer. The participants of the conference emphasized the novelty of the results presented by E.V. Denisova. They highlighted the importance to study the causes of malignant transformation of pre-tumor changes and development of non-invasive markers to predict the risk of lung cancer.
The study was supported by the RFBR grant No. 17-29-06002, the results were published in the journal Applied Immunohistochemistry & Molecular Morphology in 2019 https://www.ncbi.nlm.nih.gov/pubmed/3089654